Searched for
ADVAMED
Hopeful of settlement between India and US over GSP conflict: AdvamedIn 2017 India was the biggest beneficiary of GSP with a subsidies worth $5.6 billion.- Stent prices under the cosh again, but who will bell the real cat?The decision is a blow for stent makers, who have been clamouring for higher prices and a system to rationalise margins instead of blanket ...
- Angioplasty cost falls up to 18 per cent on stent price capAngioplasty cost at corporate hospital chains came down by 8-12% to ₹2.05 lakh-2.20 lakh from ₹2.10 lakh-2.20 lakh, the study showed.
- Drug MNCs lobby against price cuts of stents & knee implantsIn the last year India’s drug regulator has slashed prices of stents and knee implants by over 70% using an emergency provision in the drug...
- US firms approach USTR against India's medical price control measuresAdvanced Medical Technology Association president Scott Whitaker requested the USTR to 'suspend or withdraw' India's benefits under General...
- Price caps hurting healthcare industry, says Preetha Reddy"Costs are rising because there is real estate, labour and then, GST. If you have to pay tax, you have to pay," Preetha Reddy said.
- India regulator wants medical devices added to price control list, document showsNPPA Chairman Bhupendra Singh said the essential medicines list - comprised of more than 350 items, most of them drugs should include ballo...
- Stent makers want government to apply differential pricing for Drug-eluting stentsDrug-eluting stents (DES) have a polymer coating over mesh that emits a drug over time that prevent blockage of arteries from recurring.
- Pharma industry wants budget to offer tax clarityThe industry players also want the government to provide a road map towards bringing down corporate income tax down to 25 per cent.
- NPPA to soon fix ceiling prices of stentsThe decision of the Department of Pharmaceuticals comes months after the Ministry of Health in July included stents in the National List of...
- NPPA likely to put ceiling on stent prices by mid-February“NPPA is requested to take further action urgently,” the department has stated in a December 21 letter to Bhupendra Singh, chairman of the ...
- Health Ministry begins work on new law for safer drugsA new law is expected to be better suited than amendments to accommodate innovations and developments in pharma and healthcare, including t...
- Health ministry invites views on easing the drug regulation processThe ministry asked associations from both industries to provide suggestions and comments on how to improve the process of approvals and cle...
- Bill makes distinction between drugs and medical devices: AdvaMedA medical device makers body said that Drug and Cosmetics Bill which is awaiting passage in Parliament will enable the industry to serve th...
- First world's discarded medical devices flood Indian marketsComplaints are coming in from the developing world about medical devices being 'dumped' or 'sold at inflated prices' by first-world countri...
- Medical devices could be a $30 bn industry in 10 years: AdvaMedMedical devices industry has the potential to touch USD 30 billion mark in the next ten years if proper regulatory framework is provided.
- Separate regulations needed for medical devices: AdvaMedMedical devices sector in India needs to be regulated in harmonisation with international practises, trade association AdvaMed has said.
- Budget 2014: Medical device industry expects incentives in R&D, manufacturing hubs and duty cutsThe association has also called for the inception of benefits such as reduced Customs duty on raw material, excise duty concessions, VAT ho...
- Budget 2014: Medical devices sector requires incentives for growthAdvaMed is seeking 'very low level' of customs duty on import of finished products and nil customs duty for the import of raw materials.
- Medical device companies urge government not to punish all for a quality lapseMedical devices industry has urged govt not to hold all players in the supply chain responsible in case a quality lapse is detected in a de...
Load More
